How Pharmacists Improve Diabetes Control and Alert Fatigue for Patients скачать в хорошем качестве

How Pharmacists Improve Diabetes Control and Alert Fatigue for Patients

Learn how pharmacists are transforming diabetes care through smart use of glucagon-like peptide-1 (GLP-1) agonists, sodium-glucose transport 2 (SGLT2) inhibitors, and continuous glucose monitoring (CGM). In this interview, Ashley Firm, PharmD, and Catherine Bourg Rebitch, PharmD, BCACP, discuss the latest ADA standards of care, the impact of newer therapies on cardiovascular disease, heart failure, and chronic kidney disease, and how to personalize diabetes technology to each patient. You’ll hear practical insights on: Using CGM data effectively while minimizing alert fatigue Helping patients overcome cost, adherence, and stigma barriers Choosing between CGMs and traditional glucose meters based on tech access and comfort Navigating insurance and Medicare requirements for CGMs and sensors Integrating lifestyle interventions (DSMES, DPP) with pharmacotherapy This conversation is ideal for pharmacists, clinicians, diabetes educators, and care teams looking to optimize diabetes management through comprehensive, patient-centered care.